Investing in Scribe Therapeutics

Andreessen Horowitz published the investment announcement “Investing in Scribe Therapeutics”. The source describes the firm’s investment activity and rationale. This dated announcement is not a claim of current ownership, a specific legal fund allocation, an exact closing date or realized investment performance.